Bioquímica y Biología Molecular y Fisiología
Departamento
![Foto de Bioquímica y Biología Molecular y Fisiología](/img/noimage.png)
![Foto de University of Leipzig](/img/noimage_org.png)
University of Leipzig
Leipzig, AlemaniaPublicaciones en colaboración con investigadores/as de University of Leipzig (13)
2020
-
Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes
Nature Genetics, Vol. 52, Núm. 1, pp. 56-73
2018
-
Tumor Cell Load and Heterogeneity Estimation from Diffusion-Weighted MRI Calibrated with Histological Data: An Example from Lung Cancer
IEEE Transactions on Medical Imaging, Vol. 37, Núm. 1, pp. 35-46
2017
-
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer
Nature Genetics, Vol. 49, Núm. 5, pp. 680-691
2016
-
Quantitative estimation of tumor cellularity based on histology data
2016 IEEE Nuclear Science Symposium, Medical Imaging Conference and Room-Temperature Semiconductor Detector Workshop, NSS/MIC/RTSD 2016
2015
-
Concomitant expression of far upstream element (FUSE) binding protein (FBP) interacting repressor (FIR) and its splice variants induce migration and invasion of non-small cell lung cancer (NSCLC) cells
Journal of Pathology, Vol. 237, Núm. 3, pp. 390-401
2014
-
Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers
Breast Cancer Research, Vol. 16
-
DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers
PLoS Genetics, Vol. 10, Núm. 4
2013
2012
-
Common variants at the 19p13.1 and ZNF365 loci are associated with ER subtypes of breast cancer and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers
Cancer Epidemiology Biomarkers and Prevention, Vol. 21, Núm. 4, pp. 645-657
-
Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers
Human Mutation, Vol. 33, Núm. 4, pp. 690-702
2011
2010
-
Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: Implications for risk prediction
Cancer Research, Vol. 70, Núm. 23, pp. 9742-9754
2009
-
The TP53 Arg72Pro and MDM2 309GT polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers
British Journal of Cancer, Vol. 101, Núm. 8, pp. 1456-1460